AIFF — Firefly Neuroscience, Inc.
NASDAQ · Technology · Software - Application
$1.09
+$0.02 (+1.87%)
Firefly Neuroscience, Inc. (AIFF) is a software - application company listed on NASDAQ. It is led by Greg Lipschitz, based in 1100 Military Road, Kenmore, NY, United States, 14217, with about 13 employees. Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
Latest reported AIFF revenue for 2025-09-30 was $388.0K. Net income was -$2.6M. Revenue was up 29.8% from 2025-06-30 to 2025-09-30. AIFF currently screens at market cap $38.8M.
Use this AIFF page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AIFF quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AIFF SEC filings page. Lician reads the product cache first so this HTML stays unique to Firefly Neuroscience, Inc. even when a live quote feed is slow.
About Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
AIFF Key Statistics
Market Cap
$38.84M
Volume
74,485
Previous Close
$1.04
Day Range
$1.01 – $1.06
EPS
$0.00
Revenue
$108.00K
Net Income
-$10.46M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-78.3%
Profit Margin
-9685.2%
Employees
13
AIFF Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $108.00K | $498.00K | $12.02M | $15.03M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$10.46M | -$2.60M | -$17.75M | -$1.13M |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | -$0.09 |
Total Assets
$4.60M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$1.81M
Operating Cash Flow
-$6.16M
Free Cash Flow
$0.00
Firefly Neuroscience, Inc. Company Information
- CEO & Director
- Greg Lipschitz
- Headquarters
- 1100 Military Road, Kenmore, NY, United States, 14217
- Website
- fireflyneuro.com
- Phone
- 888-237-6412
- IPO / Founded
- 2011-02-23
- Sector
- Technology
- Industry
- Software - Application